Envision Pharma Group acquires OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions
Synergie Medication Collective (Synergie) is a new medication contracting organization founded by a group of Blue Cross and Blue Shield affiliated companies to serve both Blues and select independent health plans
Investment positions Orsini Specialty Pharmacy for continued expansion of patient access and support services across therapies for highly complex and rare diseases
IntegriChain acquisition of Blue Fin Group expands its commercialization capabilities and strengthens the company’s market access expertise
Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers
Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs
PANTHERx Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, unveiled a new, sophisticated and modern brand identity recently while simultaneously announcing a new, state-of-the-art third location. PANTHERx’s third location, near the Pittsburgh International Airport, will add nearly 50,000 square feet of state-of-the-art operational capacity to PANTHERx’s operations. The third site will join current facilities in Pittsburgh and Canfield, Ohio. This new […]